GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of week 71 check-in — 17kg down, fatigue manageable, one thing confusing me — 55 comments in the full submission. View in context.
4.1k
c/tirzepatide·submitted 1 year ago by u/piotr_nascimento

week 71 check-in — 17kg down, fatigue manageable, one thing confusing me

Resultsbranch of 9 comments

Been lurking in c/orforglipron for about 10 months and finally have something worth posting. Short version: week 96, 12.5mg, and dual agonist is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 35 threads, and the answers split roughly down the middle. What I actually want…

Read the full submission and all 55 comments →

This branch

9 comments, started 1 year ago
u/elin_varga389 points·1 year ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/piotr_nascimentoOP234 points·1 year ago

dual agonism is SURPASS, do not generalise from semaglutide

replysharereportpermalink
u/piotr_nascimentoOP234 points·1 year ago

Switched from sema at 7.5mg to tirz at 15mg. Different drugs, cannot compare the doses directly.

replysharereportpermalink
u/coring_the_stopper82 points·1 year ago

the appetite change on tirz is more than just reduced hunger, it is different machinery

replysharereportpermalink
u/priya_guerrero311 points·1 year ago

the dual agonism hits different and that is why people describe it differently

replysharereportpermalink
u/hana_pereira82 points·1 year ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
u/piotr_nascimentoOP44 points·1 year ago

Week 35 on Mounjaro and 11kg down. The appetite reduction feels different from sema in ways I do not have words for yet.

replysharereportpermalink
u/emil_okwuosa0 points·1 year ago

the dual agonism hits different and that is why people describe it differently

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.